European Organisation for Research and Treatment of Cancer
@eortc.org
We define better treatments for all cancer patients to prolong survival and improve quality of life.
Pinned
📅 Save the date!
EORTC events are back in 2026 ⬇️
#CancerResearch #ClinicalTrials #Oncology #EORTCevents
EORTC events are back in 2026 ⬇️
#CancerResearch #ClinicalTrials #Oncology #EORTCevents
At the #BHPA Symposium in Bruges, Enrico Clementel presented E²‑RADIatE, the largest international programme collecting real‑world data to answer radiotherapy‑specific questions, including insights from OligoCare, ReCare and SPRINT.
👏 Congratulations on the presentation.
#Radiotherapy #BHPA2026
👏 Congratulations on the presentation.
#Radiotherapy #BHPA2026
January 30, 2026 at 3:29 PM
At the #BHPA Symposium in Bruges, Enrico Clementel presented E²‑RADIatE, the largest international programme collecting real‑world data to answer radiotherapy‑specific questions, including insights from OligoCare, ReCare and SPRINT.
👏 Congratulations on the presentation.
#Radiotherapy #BHPA2026
👏 Congratulations on the presentation.
#Radiotherapy #BHPA2026
Why does funding for clinical research matter?
Because #ClinicalTrials depend on sustained investment to advance cancer treatment and provide better outcomes for patients.
👉 Like and reshare this message to highlight why cancer research matters.
#WorldCancerDay #EORTCimpact #CancerResearch
Because #ClinicalTrials depend on sustained investment to advance cancer treatment and provide better outcomes for patients.
👉 Like and reshare this message to highlight why cancer research matters.
#WorldCancerDay #EORTCimpact #CancerResearch
January 30, 2026 at 11:04 AM
Why does funding for clinical research matter?
Because #ClinicalTrials depend on sustained investment to advance cancer treatment and provide better outcomes for patients.
👉 Like and reshare this message to highlight why cancer research matters.
#WorldCancerDay #EORTCimpact #CancerResearch
Because #ClinicalTrials depend on sustained investment to advance cancer treatment and provide better outcomes for patients.
👉 Like and reshare this message to highlight why cancer research matters.
#WorldCancerDay #EORTCimpact #CancerResearch
Reposted by European Organisation for Research and Treatment of Cancer
👏 Recently published in Pediatric Blood & Cancer: SIOP abstract by Chiara Vetrano about @eortc.org #QualityofLife Group systematic review mapping key HRQOL aspects for children with cancer under 8 years to refine PRO assessment in this population.
🔗 doi.org/10.1002/pbc....
#GivingVoice2Patients
🔗 doi.org/10.1002/pbc....
#GivingVoice2Patients
January 29, 2026 at 8:41 AM
👏 Recently published in Pediatric Blood & Cancer: SIOP abstract by Chiara Vetrano about @eortc.org #QualityofLife Group systematic review mapping key HRQOL aspects for children with cancer under 8 years to refine PRO assessment in this population.
🔗 doi.org/10.1002/pbc....
#GivingVoice2Patients
🔗 doi.org/10.1002/pbc....
#GivingVoice2Patients
📅 Save the date!
EORTC events are back in 2026 ⬇️
#CancerResearch #ClinicalTrials #Oncology #EORTCevents
EORTC events are back in 2026 ⬇️
#CancerResearch #ClinicalTrials #Oncology #EORTCevents
January 29, 2026 at 3:07 PM
📅 Save the date!
EORTC events are back in 2026 ⬇️
#CancerResearch #ClinicalTrials #Oncology #EORTCevents
EORTC events are back in 2026 ⬇️
#CancerResearch #ClinicalTrials #Oncology #EORTCevents
Why do academic #ClinicalTrials matter?
Because they show which treatments truly benefit patients.
Roger, an EORTC trial participant, shares why independent, non‑commercial cancer research is essential.
👉 Like & reshare to spread the word.
#WorldCancerDay #EORTCimpact#LeavingNoCancerPatientBehind
Because they show which treatments truly benefit patients.
Roger, an EORTC trial participant, shares why independent, non‑commercial cancer research is essential.
👉 Like & reshare to spread the word.
#WorldCancerDay #EORTCimpact#LeavingNoCancerPatientBehind
January 28, 2026 at 1:56 PM
Why do academic #ClinicalTrials matter?
Because they show which treatments truly benefit patients.
Roger, an EORTC trial participant, shares why independent, non‑commercial cancer research is essential.
👉 Like & reshare to spread the word.
#WorldCancerDay #EORTCimpact#LeavingNoCancerPatientBehind
Because they show which treatments truly benefit patients.
Roger, an EORTC trial participant, shares why independent, non‑commercial cancer research is essential.
👉 Like & reshare to spread the word.
#WorldCancerDay #EORTCimpact#LeavingNoCancerPatientBehind
👏 Findings of a new international study by Lisa Wintner et al. in @thelancetoncol.bsky.social highlight the importance of integrating the patient’s voice into routine clinical evaluations and cancer research
👉 Read more: www.eortc.org/blog/2026/01...
#CancerResearch #QualityofLife @qol.eortc.org
👉 Read more: www.eortc.org/blog/2026/01...
#CancerResearch #QualityofLife @qol.eortc.org
January 28, 2026 at 11:37 AM
👏 Findings of a new international study by Lisa Wintner et al. in @thelancetoncol.bsky.social highlight the importance of integrating the patient’s voice into routine clinical evaluations and cancer research
👉 Read more: www.eortc.org/blog/2026/01...
#CancerResearch #QualityofLife @qol.eortc.org
👉 Read more: www.eortc.org/blog/2026/01...
#CancerResearch #QualityofLife @qol.eortc.org
📢 A couple of days left to apply to #MCCRWorkshop!
Have you submitted your application?
⏳ Deadline: 30 January 2026
📅 13–18 June 2026
👉 Submit your application here: https://event.eortc.org/mccr2026/application-submission/
#ClinicalTrialDesign #ClinicalResearch
Have you submitted your application?
⏳ Deadline: 30 January 2026
📅 13–18 June 2026
👉 Submit your application here: https://event.eortc.org/mccr2026/application-submission/
#ClinicalTrialDesign #ClinicalResearch
January 28, 2026 at 11:00 AM
📢 A couple of days left to apply to #MCCRWorkshop!
Have you submitted your application?
⏳ Deadline: 30 January 2026
📅 13–18 June 2026
👉 Submit your application here: https://event.eortc.org/mccr2026/application-submission/
#ClinicalTrialDesign #ClinicalResearch
Have you submitted your application?
⏳ Deadline: 30 January 2026
📅 13–18 June 2026
👉 Submit your application here: https://event.eortc.org/mccr2026/application-submission/
#ClinicalTrialDesign #ClinicalResearch
📢 New findings in @JAMANetworkOpen.
Using data from five randomized trials, potent ALDH1A1‑activating PPIs were linked to reduced survival in patients with newly diagnosed glioblastoma. Other antacids showed no such effect.
🔗 www.eortc.org/publications/
#ClinicalResearch
Using data from five randomized trials, potent ALDH1A1‑activating PPIs were linked to reduced survival in patients with newly diagnosed glioblastoma. Other antacids showed no such effect.
🔗 www.eortc.org/publications/
#ClinicalResearch
January 27, 2026 at 2:33 PM
📢 New findings in @JAMANetworkOpen.
Using data from five randomized trials, potent ALDH1A1‑activating PPIs were linked to reduced survival in patients with newly diagnosed glioblastoma. Other antacids showed no such effect.
🔗 www.eortc.org/publications/
#ClinicalResearch
Using data from five randomized trials, potent ALDH1A1‑activating PPIs were linked to reduced survival in patients with newly diagnosed glioblastoma. Other antacids showed no such effect.
🔗 www.eortc.org/publications/
#ClinicalResearch
📚 A week that makes a real difference.
Step back, refine your clinical trial protocol, receive continuous expert feedback and build lasting scientific connections.
📅 13–18 June 2026
⏳ Applications close 30 January 2026
👉 Apply now: https://event.eortc.org/mccr2026/application-submission/
Step back, refine your clinical trial protocol, receive continuous expert feedback and build lasting scientific connections.
📅 13–18 June 2026
⏳ Applications close 30 January 2026
👉 Apply now: https://event.eortc.org/mccr2026/application-submission/
January 27, 2026 at 9:30 AM
📚 A week that makes a real difference.
Step back, refine your clinical trial protocol, receive continuous expert feedback and build lasting scientific connections.
📅 13–18 June 2026
⏳ Applications close 30 January 2026
👉 Apply now: https://event.eortc.org/mccr2026/application-submission/
Step back, refine your clinical trial protocol, receive continuous expert feedback and build lasting scientific connections.
📅 13–18 June 2026
⏳ Applications close 30 January 2026
👉 Apply now: https://event.eortc.org/mccr2026/application-submission/
🚀 Milestones achieved for VIGOR (EORTC‑2427‑BTG)!
The first site is activated and the first patient has already been randomised in this Phase III study evaluating vorasidenib for IDH‑mutant astrocytoma.
A strong start for this international effort.
🔗 www.eortc.org/blog/2026/01...
The first site is activated and the first patient has already been randomised in this Phase III study evaluating vorasidenib for IDH‑mutant astrocytoma.
A strong start for this international effort.
🔗 www.eortc.org/blog/2026/01...
January 26, 2026 at 12:12 PM
🚀 Milestones achieved for VIGOR (EORTC‑2427‑BTG)!
The first site is activated and the first patient has already been randomised in this Phase III study evaluating vorasidenib for IDH‑mutant astrocytoma.
A strong start for this international effort.
🔗 www.eortc.org/blog/2026/01...
The first site is activated and the first patient has already been randomised in this Phase III study evaluating vorasidenib for IDH‑mutant astrocytoma.
A strong start for this international effort.
🔗 www.eortc.org/blog/2026/01...
Cancer clinical trials turn discoveries into better treatments. EORTC leads international trials, studying not just if treatments work, but how they improve patients’ quality of life.
👉 Like & reshare to raise awareness. #WorldCancerDay #ClinicalTrials #EORTCimpact
👉 Like & reshare to raise awareness. #WorldCancerDay #ClinicalTrials #EORTCimpact
January 23, 2026 at 12:01 PM
Cancer clinical trials turn discoveries into better treatments. EORTC leads international trials, studying not just if treatments work, but how they improve patients’ quality of life.
👉 Like & reshare to raise awareness. #WorldCancerDay #ClinicalTrials #EORTCimpact
👉 Like & reshare to raise awareness. #WorldCancerDay #ClinicalTrials #EORTCimpact
🎓Tomorrow is International Day of Education, a moment to celebrate the EORTC Early Career Investigator (ECI) programme, which empowers young doctors to drive #CancerResearch forward.
Meet Ioannis, Jens & Antonella from our ECI community.
Join us: https://www.eortc.org/early-career/
Meet Ioannis, Jens & Antonella from our ECI community.
Join us: https://www.eortc.org/early-career/
January 23, 2026 at 8:31 AM
🎓Tomorrow is International Day of Education, a moment to celebrate the EORTC Early Career Investigator (ECI) programme, which empowers young doctors to drive #CancerResearch forward.
Meet Ioannis, Jens & Antonella from our ECI community.
Join us: https://www.eortc.org/early-career/
Meet Ioannis, Jens & Antonella from our ECI community.
Join us: https://www.eortc.org/early-career/
Reposted by European Organisation for Research and Treatment of Cancer
📣 Registration is now open for the @eortc.org #QualityofLife Group (QLG) spring meeting 2026.
📅 16-17 April
📍 Berlin, Germany
🔗 Registration link sent to all EORTC QLG members by email today ✉️
🔎 More info on venue, programme, etc, available here: www.eortc.org/event/eortc-...
#QLGmeeting
📅 16-17 April
📍 Berlin, Germany
🔗 Registration link sent to all EORTC QLG members by email today ✉️
🔎 More info on venue, programme, etc, available here: www.eortc.org/event/eortc-...
#QLGmeeting
January 21, 2026 at 10:31 AM
📣 Registration is now open for the @eortc.org #QualityofLife Group (QLG) spring meeting 2026.
📅 16-17 April
📍 Berlin, Germany
🔗 Registration link sent to all EORTC QLG members by email today ✉️
🔎 More info on venue, programme, etc, available here: www.eortc.org/event/eortc-...
#QLGmeeting
📅 16-17 April
📍 Berlin, Germany
🔗 Registration link sent to all EORTC QLG members by email today ✉️
🔎 More info on venue, programme, etc, available here: www.eortc.org/event/eortc-...
#QLGmeeting
Advancing cancer research often starts with this question: how can we improve cancer treatment for everyone?
Ahead of #WorldCancerDay, we’ll share insights from clinical research & stories from patients whose lives have been changed by clinical trials.
Stay tuned.
#EORTCimpact
Ahead of #WorldCancerDay, we’ll share insights from clinical research & stories from patients whose lives have been changed by clinical trials.
Stay tuned.
#EORTCimpact
January 21, 2026 at 11:27 AM
Advancing cancer research often starts with this question: how can we improve cancer treatment for everyone?
Ahead of #WorldCancerDay, we’ll share insights from clinical research & stories from patients whose lives have been changed by clinical trials.
Stay tuned.
#EORTCimpact
Ahead of #WorldCancerDay, we’ll share insights from clinical research & stories from patients whose lives have been changed by clinical trials.
Stay tuned.
#EORTCimpact
📢 EORTC & ema.europa.eu, together with key multiple international stakeholders, release a new CMF roadmap setting a clear direction for advancing treatment optimisation across Europe. A meaningful step toward more effective and sustainable cancer care.
Read more here: www.eortc.org/blog/2026/01...
Read more here: www.eortc.org/blog/2026/01...
January 16, 2026 at 12:37 PM
📢 EORTC & ema.europa.eu, together with key multiple international stakeholders, release a new CMF roadmap setting a clear direction for advancing treatment optimisation across Europe. A meaningful step toward more effective and sustainable cancer care.
Read more here: www.eortc.org/blog/2026/01...
Read more here: www.eortc.org/blog/2026/01...
📢 Join our team! EORTC is recruiting a Clinical Data Manager at its HQ in Brussels.
Do you hold a bachelor’s or master’s degree in a health or life sciences field and want to contribute to high-quality cancer research?👉
Apply now: https://ow.ly/Xa4x50XXipJ
Do you hold a bachelor’s or master’s degree in a health or life sciences field and want to contribute to high-quality cancer research?👉
Apply now: https://ow.ly/Xa4x50XXipJ
January 15, 2026 at 3:42 PM
📢 Join our team! EORTC is recruiting a Clinical Data Manager at its HQ in Brussels.
Do you hold a bachelor’s or master’s degree in a health or life sciences field and want to contribute to high-quality cancer research?👉
Apply now: https://ow.ly/Xa4x50XXipJ
Do you hold a bachelor’s or master’s degree in a health or life sciences field and want to contribute to high-quality cancer research?👉
Apply now: https://ow.ly/Xa4x50XXipJ
Reposted by European Organisation for Research and Treatment of Cancer
📄Findings of a new @eortc.org #QualityofLife publication in Critical Reviews in Oncology/Hematology highlight the need for improved reporting & greater prioritisation of PRO completion regardless of trial design.
🔗 doi.org/10.1016/j.cr...
#GivingVoice2Patients #CancerResearch
@msztankay.bsky.social
🔗 doi.org/10.1016/j.cr...
#GivingVoice2Patients #CancerResearch
@msztankay.bsky.social
January 15, 2026 at 1:31 PM
📄Findings of a new @eortc.org #QualityofLife publication in Critical Reviews in Oncology/Hematology highlight the need for improved reporting & greater prioritisation of PRO completion regardless of trial design.
🔗 doi.org/10.1016/j.cr...
#GivingVoice2Patients #CancerResearch
@msztankay.bsky.social
🔗 doi.org/10.1016/j.cr...
#GivingVoice2Patients #CancerResearch
@msztankay.bsky.social
📢 Don’t miss the opportunity to take part in this once-in-a-lifetime workshop.
💬 Feedback from 2025 participants of the #MCCRWorkshop
📅 13–18 June 2026
🚨Deadline: 30 January 2026
👉 Apply now: https://event.eortc.org/mccr2026/application-submission/
#clinicaltrials #clinicaltrialdesign
💬 Feedback from 2025 participants of the #MCCRWorkshop
📅 13–18 June 2026
🚨Deadline: 30 January 2026
👉 Apply now: https://event.eortc.org/mccr2026/application-submission/
#clinicaltrials #clinicaltrialdesign
January 15, 2026 at 12:01 PM
📢 Don’t miss the opportunity to take part in this once-in-a-lifetime workshop.
💬 Feedback from 2025 participants of the #MCCRWorkshop
📅 13–18 June 2026
🚨Deadline: 30 January 2026
👉 Apply now: https://event.eortc.org/mccr2026/application-submission/
#clinicaltrials #clinicaltrialdesign
💬 Feedback from 2025 participants of the #MCCRWorkshop
📅 13–18 June 2026
🚨Deadline: 30 January 2026
👉 Apply now: https://event.eortc.org/mccr2026/application-submission/
#clinicaltrials #clinicaltrialdesign
The final analysis of the CATNON trial is now published in The Lancet Oncology.
This landmark study helps define a new standard of care for patients with 1p/19q non-codeleted anaplastic glioma, building on results presented at #EANO2025.
🔗 https://ow.ly/WpKF50XWa0G
#EORTC #CATNON #NeuroOncology
This landmark study helps define a new standard of care for patients with 1p/19q non-codeleted anaplastic glioma, building on results presented at #EANO2025.
🔗 https://ow.ly/WpKF50XWa0G
#EORTC #CATNON #NeuroOncology
January 13, 2026 at 3:30 PM
The final analysis of the CATNON trial is now published in The Lancet Oncology.
This landmark study helps define a new standard of care for patients with 1p/19q non-codeleted anaplastic glioma, building on results presented at #EANO2025.
🔗 https://ow.ly/WpKF50XWa0G
#EORTC #CATNON #NeuroOncology
This landmark study helps define a new standard of care for patients with 1p/19q non-codeleted anaplastic glioma, building on results presented at #EANO2025.
🔗 https://ow.ly/WpKF50XWa0G
#EORTC #CATNON #NeuroOncology
👏 Earlier today, Ana Joaquim took part in the EHNS workshop on Perioperative Immunotherapy for Head and Neck Cancer in Lausanne.
She joined the expert panel “Adjuvant, neo‑adjuvant or both?” this morning, contributing to discussions on optimising perioperative strategies for patients. 🔬
She joined the expert panel “Adjuvant, neo‑adjuvant or both?” this morning, contributing to discussions on optimising perioperative strategies for patients. 🔬
January 9, 2026 at 3:42 PM
👏 Earlier today, Ana Joaquim took part in the EHNS workshop on Perioperative Immunotherapy for Head and Neck Cancer in Lausanne.
She joined the expert panel “Adjuvant, neo‑adjuvant or both?” this morning, contributing to discussions on optimising perioperative strategies for patients. 🔬
She joined the expert panel “Adjuvant, neo‑adjuvant or both?” this morning, contributing to discussions on optimising perioperative strategies for patients. 🔬
📄 New in @jamanetworkopen.com
Researchers led by Sam Sodergren have developed a new EORTC #QoL questionnaire for adolescents & young adults with cancer – capturing challenges &positive adaptations unique to this age group.
👉 www.eortc.org/blog/2026/01...
@sotonhsciences.bsky.social @qol.eortc.org
Researchers led by Sam Sodergren have developed a new EORTC #QoL questionnaire for adolescents & young adults with cancer – capturing challenges &positive adaptations unique to this age group.
👉 www.eortc.org/blog/2026/01...
@sotonhsciences.bsky.social @qol.eortc.org
January 8, 2026 at 1:20 PM
📄 New in @jamanetworkopen.com
Researchers led by Sam Sodergren have developed a new EORTC #QoL questionnaire for adolescents & young adults with cancer – capturing challenges &positive adaptations unique to this age group.
👉 www.eortc.org/blog/2026/01...
@sotonhsciences.bsky.social @qol.eortc.org
Researchers led by Sam Sodergren have developed a new EORTC #QoL questionnaire for adolescents & young adults with cancer – capturing challenges &positive adaptations unique to this age group.
👉 www.eortc.org/blog/2026/01...
@sotonhsciences.bsky.social @qol.eortc.org
Reposted by European Organisation for Research and Treatment of Cancer
📘 Just published:
M Petersen et al. evaluated the use of cross-domain prediction to tailor start item selection in the @eortc.org CAT Core. Results suggest improved measurement precision for short computer-adaptive tests (CATs).
👉 doi.org/10.1007/s111...
#QualityofLife @mogensgroenvold.bsky.social
M Petersen et al. evaluated the use of cross-domain prediction to tailor start item selection in the @eortc.org CAT Core. Results suggest improved measurement precision for short computer-adaptive tests (CATs).
👉 doi.org/10.1007/s111...
#QualityofLife @mogensgroenvold.bsky.social
January 6, 2026 at 2:59 PM
📘 Just published:
M Petersen et al. evaluated the use of cross-domain prediction to tailor start item selection in the @eortc.org CAT Core. Results suggest improved measurement precision for short computer-adaptive tests (CATs).
👉 doi.org/10.1007/s111...
#QualityofLife @mogensgroenvold.bsky.social
M Petersen et al. evaluated the use of cross-domain prediction to tailor start item selection in the @eortc.org CAT Core. Results suggest improved measurement precision for short computer-adaptive tests (CATs).
👉 doi.org/10.1007/s111...
#QualityofLife @mogensgroenvold.bsky.social
📢 Don’t miss the EORTC webinar Patient Preferences Matter, happening this Friday, 9 January 2026.
🔗 For more information: www.eortc.org/event/joint-...
#PatientPreferences #CancerResearch #EORTC #ClinicalTrials
🔗 For more information: www.eortc.org/event/joint-...
#PatientPreferences #CancerResearch #EORTC #ClinicalTrials
How much do patient preferences shape cancer research?
Join our webinar with OAC & @qol.eortc.org to explore why listening to patients, especially older adults, matters.
🗓 Jan 9, 2026 | 17:00–18:30 CET
🔗 Registration soon: www.eortc.org/event/joint-...
#CancerCare #OlderAdults
Join our webinar with OAC & @qol.eortc.org to explore why listening to patients, especially older adults, matters.
🗓 Jan 9, 2026 | 17:00–18:30 CET
🔗 Registration soon: www.eortc.org/event/joint-...
#CancerCare #OlderAdults
January 7, 2026 at 3:42 PM
📢 Don’t miss the EORTC webinar Patient Preferences Matter, happening this Friday, 9 January 2026.
🔗 For more information: www.eortc.org/event/joint-...
#PatientPreferences #CancerResearch #EORTC #ClinicalTrials
🔗 For more information: www.eortc.org/event/joint-...
#PatientPreferences #CancerResearch #EORTC #ClinicalTrials
We were honoured to welcome Princess Laetitia of Belgium to EORTC HQ last week! Ahead of her Edinburgh Marathon 2026 run for cancer research, she met our CEO Denis Lacombe, MD and learned about EORTC’s mission to advance cancer treatments.
Grateful for her commitment!
#Oncology
Grateful for her commitment!
#Oncology
December 23, 2025 at 11:33 AM
We were honoured to welcome Princess Laetitia of Belgium to EORTC HQ last week! Ahead of her Edinburgh Marathon 2026 run for cancer research, she met our CEO Denis Lacombe, MD and learned about EORTC’s mission to advance cancer treatments.
Grateful for her commitment!
#Oncology
Grateful for her commitment!
#Oncology
📢 Our December EORTC Newsletter is out!
Featuring key milestones, research highlights, and upcoming initiatives.
👉 Read the latest edition: us2.campaign-archive.com.
#CancerResearch #EORTC #Oncology
Featuring key milestones, research highlights, and upcoming initiatives.
👉 Read the latest edition: us2.campaign-archive.com.
#CancerResearch #EORTC #Oncology
December 19, 2025 at 3:30 PM
📢 Our December EORTC Newsletter is out!
Featuring key milestones, research highlights, and upcoming initiatives.
👉 Read the latest edition: us2.campaign-archive.com.
#CancerResearch #EORTC #Oncology
Featuring key milestones, research highlights, and upcoming initiatives.
👉 Read the latest edition: us2.campaign-archive.com.
#CancerResearch #EORTC #Oncology